Truist Financial Forecasts Strong Price Appreciation for AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth (NASDAQ:AHCO) had its price target increased by analysts at Truist Financial from $12.00 to $14.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price would indicate a potential upside of 31.58% from the company’s current price.

A number of other research analysts have also issued reports on AHCO. Canaccord Genuity Group reduced their price objective on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. UBS Group reduced their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Royal Bank of Canada dropped their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Tuesday, November 19th. Finally, Robert W. Baird cut their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth presently has a consensus rating of “Buy” and an average price target of $12.60.

AdaptHealth Stock Performance

AHCO stock opened at $10.64 on Wednesday. The stock’s 50 day simple moving average is $9.84 and its 200 day simple moving average is $10.20. AdaptHealth has a 12-month low of $7.25 and a 12-month high of $11.90. The firm has a market cap of $1.43 billion, a P/E ratio of -6.45, a P/E/G ratio of 1.08 and a beta of 1.12. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.

Institutional Investors Weigh In On AdaptHealth

Large investors have recently made changes to their positions in the company. Pacer Advisors Inc. acquired a new stake in AdaptHealth in the 4th quarter worth approximately $76,271,000. Principal Financial Group Inc. raised its position in shares of AdaptHealth by 204.0% in the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock valued at $15,735,000 after purchasing an additional 1,109,021 shares during the period. Segall Bryant & Hamill LLC lifted its stake in shares of AdaptHealth by 29.8% in the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock worth $45,734,000 after buying an additional 1,102,173 shares during the last quarter. State Street Corp boosted its holdings in shares of AdaptHealth by 19.8% during the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after buying an additional 681,816 shares during the period. Finally, FMR LLC grew its stake in AdaptHealth by 9.3% in the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock valued at $82,547,000 after buying an additional 624,645 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.